In view of the recent findings showing the detrimental effect of neutralizing anti-IFN-Abs in patients with COVID-19, it is important to understand the impact of neutralizing anti-IFN-Abs on “nascent” IFNα produced by challenged pDCs and how this affects healthy B cell differentiation. This evidence concerns the gene IFNA1 and COVID-19.